Androgens influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro.

Estrogen formed perinatally in the brain from testicular androgen by aromatase is involved in the irreversible determination of male brain development. Perinatal sex differences in aromatase activity have been observed in the hypothalamus. Testosterone (T) is a major modulator for aromatase in the adult rat hypothalamus. However, it is not known whether circulating T influences aromatase neurons during fetal brain development. To study the influence of androgen exposure on embryonic neuronal aromatase, gender-specific primary cell cultures were prepared from embryonic day 15 mouse hypothalamus and cortex. Estrogen formation by cultured neurons was measured using an in vitro 3H2O product formation assay, and aromatase neurons were identified by immunocytochemistry using a highly specific antiserum. Aromatase activity (AA) per well and numbers of aromatase-immunoreactive (IR) neurons per microtubulus associated protein II-IR neurons x 10(5) were significantly higher in male hypothalamic cultures compared with female when grown in the absence of sex steroids. When AA was calculated per aromatase-IR neuron, no differences in enzyme activity were found between male and female. Therefore, the level of AA in individual male hypothalamic neurons is similar to the female, but a higher proportion of male neurons express aromatase. After T treatment, AA per well (P < or = 0.001) and AA/aromatase-IR cell (P < or = 0.005) in male and female hypothalamic cultures was significantly increased vs. controls. In addition, numbers of aromatase-IR neurons/microtubulus associated protein II-IR neurons x 10(5) were significantly higher after T exposure compared with controls (P < 0.001). Androgenic effects on hypothalamic AA and aromatase-IR cell numbers were dose-dependent and mediated via androgen receptor stimulation, since the observed effects were inhibited by the androgen-receptor antagonist flutamide. There was no effect of T on cortical AA or aromatase-IR cell numbers, indicating area-specific regulation of brain aromatase. We conclude that 1) sex differences in hypothalamic AA are due to a higher percentage of neurons expressing aromatase in males rather than to higher AA in individual male hypothalamic aromatase-IR cells, and 2) androgens influence the development of the fetal hypothalamic aromatase system. Because T influenced both the embryonic male and female hypothalamic neurons in culture, the developing mouse brain aromatase appears to be bipotential in response to androgen. The data suggest that environmental and genetic factors affecting androgen level and/or androgen receptor function in the developing brain could interfere with the sexual differentiation of estrogen forming neurons.

Aromatase-immunoreactivity is localised specifically in neurones in the developing mouse hypothalamus and cortex.

Local formation of oestrogens from androgens by aromatase cytochrome P-450 within brain cells is crucial for the sexual differentiation of the mammalian CNS. Aromatase activity has been detected in several brain regions of the developing rodent brain. In the present study, we used a mouse-specific, peptide-generated, polyclonal aromatase antibody to determine whether neurones and/or glial cells in the developing brain are involved in androgen aromatization and if aromatase-immunoreactive (Arom-IR) cells exhibit a sex-specific distribution and regional-specific morphological characteristics. For these experiments, gender-specific cell cultures were prepared from embryonic day 15 mouse hypothalamus and cortex. Specificity of the immunoreaction was confirmed by Western-blot analysis and by inhibition of aromatase activity using tissue homogenates from mouse ovaries and male newborn hypothalamus and from male hypothalamic cultures with known aromatase activity, respectively. Arom-IR cells were found in both hypothalamic and cortical cultures. Double-labeling experiments revealed that Arom-IR cells co-stained only for the neuronal marker MAP II, but never for glial markers. Therefore aromatase immunoreactivity is specifically neuronal. Regional differences in the morphology of Arom-IR neurones were observed between both brain regions. In hypothalamic cultures, IR-neurones represented a heterologous population of phenotypes (magnocellular, small bipolar and multipolar neurones with long processes showing varicose-like structures or without processes). Cortical Arom-IR neurones were always oval in shape with short or no IR-processes. Sexual dimorphisms in numbers of Arom-IR neurones were found in the hypothalamus with significantly higher cell numbers in male cultures.(ABSTRACT TRUNCATED AT 250 WORDS)

An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advances breast cancer undergoing oophorectomy: a later analysis.

In 1977 we reported our results of an ongoing randomized clinical trial evaluating early or delayed adjuvant chemotherapy utilizing 5-flourouracil, cytoxan and prednisone in premenopausal patients with recurrent or advanced breast cancer. At that time the group receiving early systemic chemotherapy was shown to have an improved progression-free interval and appeared to have a trend toward improved survival. The results of subsequent analysis after over 4 more years of follow-up indicate however, that while early employment of systemic chemotherapy does indeed prolong the progression-free interval, and while this advantage has been maintained, there is no survival advantage shown for either group of patients.